DERMAX
Country: Israel
Language: English
Source: Ministry of Health
Patient Information leaflet
(PIL)
24-03-2019
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
TRICLOSAN
Available from:
FISCHER PHARMACEUTICALS LTD
ATC code:
D08AE
Pharmaceutical form:
SOLUTION
Composition:
TRICLOSAN 1 %V/V
Administration route:
TOPICAL
Prescription type:
Not required
Manufactured by:
TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL
Therapeutic group:
PHENOL AND DERIVATIVES
Therapeutic indications:
For treatment and disinfection of skin infections .
Authorization date:
2023-07-24
